Ran Frenkel Email Address

Chief Executive Officer

Karyopharm is a clinical-stage pharmaceutical company focused on discovery and development of novel drugs for the treatment of cancer ...

With over 23 years of experience in the Pharmaceutical industry, holding international roles in various levels of senior management, business development and fund raising, b2b licensing, drug development, strategy and marketing my career spans experience of working across a large number of companies from the smallest start-up ventures, through Biotech and Medical Device companies to large Contract Research Organizations (CROs) and pharmaceutical companies. I have international industry experience and a global network of medical, scientific and business contacts within pharmaceutical companies, hospitals, KOLs, academic canters, regulatory agencies, distributors, health insurance companies and financial institutions. In several companies I have established the legal entities in new or developed markets where there was no existing infrastructure, and brought the companies into full operations and revenue generation. In December 2015 I received a US O-1 classification visa as an individual with extraordinary ability and expertise in business and management, specifically in the pharmaceutical industry. I am in the executive management team of a US based pharmaceutical company, Karyopharm Therapeutics as of October 2014, establishing the first ex-US subsidiary in Europe. Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company focused on discovery and development and subsequent commercialization of novel first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases.